Dr. LeBoeuf is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
281 Lincoln St
# Med
Worcester, MA 01605Phone+1 508-334-8015Fax+1 617-582-6060
Education & Training
- University of Massachusetts Medical SchoolClass of 2006
Certifications & Licensure
- ME State Medical License Current
- MA State Medical License 2010 - 2025
- NY State Medical License 2008 - 2014
- American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- Fellow (FAAD) American Academy of Dermatology
Publications & Presentations
PubMed
- A neoantigen vaccine generates antitumour immunity in renal cell carcinoma.David A Braun, Giorgia Moranzoni, Vipheaviny Chea, Bradley A McGregor, Eryn Blass
Nature. 2025-02-05 - NRAS tumor mutations are associated with reduced odds of dermatologic adverse events in patients with metastatic melanoma receiving immune checkpoint inhibitors.Michael S Chang, Jordan T Said, Elliot H Akama-Garren, Nicole Trepanowski, Ai-Tram N Bui
JAAD International. 2025-02-01 - Dermatofibrosarcoma Protuberans, Version 1.2025, NCCN Clinical Practice Guidelines In Oncology.Jeremy Bordeaux, Rachel Blitzblau, Sumaira Z Aasi, Murad Alam, Arya Amini
Journal of the National Comprehensive Cancer Network. 2025-01-01
Press Mentions
- Oral Retinoid May Ease Painful Skin Reactions to Anticancer TherapyMay 13th, 2022
- Awards, Honors, and GrantsSeptember 8th, 2023
- Despite Decades of Promises, Health Research Still Overlooks Women | Medical ResearchNovember 21st, 2023
- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: